Vimarsana
Biggest News Aggregation in the World

Safety Evaluation Team News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Safety Evaluation Team. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Safety Evaluation Team Today - Breaking & Trending Today

Geron : Fiscal Year 2023 Annual Report -March 28, 2024 at 06:52 am EDT - Vimarsana News

Geron : Fiscal Year 2023 Annual Report -March 28, 2024 at 06:52 am EDT

2023 Annual Report Letter to Stockholders 2024 Proxy Statement 2023 Annual Report on Form 10-K ...

Geron Corporation (NASDAQ:GERN) Q4 2023 Earnings Call Transcript - Vimarsana News

Geron Corporation (NASDAQ:GERN) Q4 2023 Earnings Call Transcript

Geron Corporation (NASDAQ:GERN) Q4 2023 Earnings Call Transcript February 28, 2024 Geron Corporation beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1. GERN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Rob and I […]

Source: yahoo.com
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

June 16, 2024 PDUFA date for imetelstat NDA for the treatment of transfusion-dependent anemia in adult patients with lower-risk MDS ...

Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results - Vimarsana News

Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results

Imetelstat is currently under regulatory review by the FDA and EMA for the treatment of transfusion-dependent anemia in adult patients with lower risk MDS Planning is ongoing for a potential...